Cyrielle Gilletta
Toulouse, 31300, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 28, 2026
Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 08, 2026
Frailty in inflammatory bowel disease: a missing link in personalized care for the aging IBD population.
Journal: Inflammatory bowel diseases
Published: December 14, 2025
Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: November 30, 2025
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 07, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
Journal: Journal of Crohn's & colitis
Published: September 10, 2025
A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.
Journal: Journal of Crohn's & colitis
Published: June 13, 2025
Sexual dysfunction in inflammatory bowel diseases: symptom-specific impact, patient perspectives, and gaps in care.
Journal: The journal of sexual medicine
Published: May 07, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Journal: Alimentary pharmacology & therapeutics
Published: March 31, 2025
Safety of Advanced Combination Treatment With Selective JAK1 Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience.
Journal: Alimentary pharmacology & therapeutics
Published: December 31, 2024
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.
Journal: The American journal of gastroenterology
Published: December 10, 2024
Last Updated: 09/26/2026